[1] |
Zhou M, Wang H, Zeng X, et al.Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: A systematic analysis for the Global[J]. Lancet, 2019,24(33):234-235.
|
[2] |
关英, 阿选德. 西宁市40岁及以上居民慢性阻塞性肺病流行病学调查[J]. 华南预防医学, 2019, 45(5): 478-480.
|
[3] |
Paschalis EP, Gamsjaeger S, Dempster D, et al.Fragility fracture incidence in chronic obstructive pulmonary disease (COPD) patients associates with nanoporosity, mineral/matrix ratio, and pyridinoline content at actively bone forming trabecular surfaces[J].J Bone Miner Res, 2016, 41(7):676-683.
|
[4] |
徐玉秀, 张岩, 高贤. 血常规检测对慢性阻塞性肺疾病患者预后预测作用[J]. 华南预防医学, 2020, 46(1): 69-71.
|
[5] |
刁鑫,兀威,张进召.吸烟对慢性阻塞性肺疾病患者CD8~+T细胞的影响[J].分子诊断与治疗杂志,2018,10(6):395-399.
|
[6] |
中华医学会呼吸病学分会慢性阻塞性肺疾病学组. 慢性阻塞性肺疾病诊治指南(2013年修订版)[J]. 全科医学临床与教育, 2013, 36(5):484-491.
|
[7] |
孙振晓, 刘化学, 焦林瑛, 等. 医院焦虑抑郁量表的信度及效度研究[J]. 中华临床医师杂志, 2017, 11(2):198-201.
|
[8] |
中国成人血脂异常防治指南制订联合委员会.中国成人血脂异常防治指南[J]. 中华心血管病杂志, 2007, 35(5): 390-419.
|
[9] |
Can U, Yerlikaya FH, Yosunkaya S.Role of oxidative stress and serum lipid levels in stable chronic obstructive pulmonary disease[J]. J Chin Med Assoc, 2015,78(12):702-708.
|
[10] |
刘萍,王永斌,高天霖,等.综合性肺康复治疗对稳定期慢性阻塞性肺疾病患者运动能力与生存质量影响[J].中国康复医学杂志,2016,31(8):884-888.
|
[11] |
Xuan L, Han F, Gong L, et al.Association between chronic obstructive pulmonary disease and serum lipid levels: a meta-analysis[J]. Lipids Health Dis, 2018, 17(1):345-346.
|
[12] |
Zhdan V, Khaymenova G, Shilkina L, et al.Determine the effectiveness of lipid-lowering therapy in patients with chronic obstructive pulmonary disease combined with coronary heart disease[J]. Wiad Lek, 2017, 70(2 pt 2):303-305.
|
[13] |
李春芝,闫莉,高俊茶,等.COPD患者脂代谢异常的变化[J]. 山西医科大学学报,2015,46(10):999-1001.
|
[14] |
Zinellu A, Fois AG, Sotgia S, et al.Arginines plasma concentration and oxidative stress in mild to moderate COPD[J]. PLoS One, 2016, 11(8):e0160237.
|